Status:

NOT_YET_RECRUITING

Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain

Lead Sponsor:

Beijing Tiantan Hospital

Collaborating Sponsors:

Beijing Xiaotangshan Hospital

The First Hospital of Fangshan District,Beijing

Conditions:

Herpes Zoster

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To assess the 1-month effects and safety of esketamine - PRF -standardized drug treatment against PRF -standardized drug treatment acute/subacute zoster-associated pain (ZAP) patients.

Detailed Description

This study aims to determine whether the addition of esketamine to PRF - standardized drug treatment can improve 1 - month pain control and safety profiles in acute/subacute ZAP patients. The findings...

Eligibility Criteria

Inclusion

  • Ages more than 18 years;
  • Patients with onset of herpes zoster (HZ) rash less than 90 days;
  • HZ affected the spinal nerves (cervical/thoracic/lumbar nerve);
  • Having an average pain score of at least 4 on a Numeric Rating Scale (NRS, 0 = no pain, 10= worst possible pain);
  • Planned to perform CT-guided PRF treatment of the dorsal root ganglion(DRG).

Exclusion

  • Obstructive sleep apnoea syndrome;
  • Those who receive other more invasive treatments, such as radiofrequency thermocoagulation (RFT) of DRG.
  • A history of systemic immune diseases, organ transplantation, or cancers;
  • A history of severe cardiopulmonary, hepatic, renal dysfunction or coagulation function disorder;
  • A history of schizophrenia, epilepsy, or myasthenia gravis, delirium;
  • Comorbid hyperthyroidism or phaeochromocytoma;
  • Recent history of drug abuse;
  • Having contraindications to esketamine;
  • Communication difficulties.
  • Women who are preparing for pregnancy, in the pregnancy or lactation period.

Key Trial Info

Start Date :

April 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

184 Patients enrolled

Trial Details

Trial ID

NCT06914206

Start Date

April 1 2025

End Date

July 1 2026

Last Update

April 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China, 100070

Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain | DecenTrialz